CLINICAL TRIAL SPONSORED RESEARCH AGREEMENTTrial Sponsored Research Agreement • February 17th, 2009 • Palatin Technologies Inc • Pharmaceutical preparations • New York
This CLINICAL TRIAL SPONSORED RESEARCH AGREEMENT (this “Agreement”) is made effective as of December 5, 2008 (the “Effective Date”), by and between PALATIN TECHNOLOGIES, INC., a Delaware corporation having an address of Cedar Brook Corporate Center, 4C Cedar Brook Drive, Cranbury, New Jersey 08512 (“Palatin”) and ASTRAZENECA AB, a company incorporated in Sweden under no. 556011-7482 with offices at S-151 85 Södertälje, Sweden (“AstraZeneca”).
